By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Lukas Biomedical Inc. (6814.TWO)

TWO Currency in TWD
$22.15
+$0.05
+0.23%
Last Update: 8 Jul 2025, 01:08
$927.52M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$16.60 - $36.00
52 Week Range

6814.TWO Stock Price Chart

Explore Lukas Biomedical Inc. interactive price chart. Choose custom timeframes to analyze 6814.TWO price movements and trends.

There is nothing to show.

6814.TWO Company Profile

Discover essential business fundamentals and corporate details for Lukas Biomedical Inc. (6814.TWO) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

31 Dec 2020

Employees

88.00

CEO

Chaoan Liu

Description

Lukas Biomedical Inc. engages in the development of immune cell medical technology for regenerative medicine and auxiliary treatment of cancer in Taiwan. It operates through four divisions: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. The company also wholesales and retails cosmetics; and rents housing equipment. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei, Taiwan.

6814.TWO Financial Timeline

Browse a chronological timeline of Lukas Biomedical Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Stock split effective on 30 Aug 2021

Shares were split 1033:1000, changing the number of shares outstanding and the price per share accordingly.

6814.TWO Stock Performance

Access detailed 6814.TWO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
6814.TWO
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
6814.TWO
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More